Global Cancer Technology, Inc. — Regulation A 1-A
Global Cancer Technology, Inc. of SAN DIEGO, CA filed a Regulation A 1-A with the SEC on 2020-09-08. Aggregate offering: $9.1M (Tier 2). Industry: Other.
Offering
- Filed: 2020-09-08
- Form: 1-A
- Accession: 0001683168-20-003056
- Tier: Tier 2
- Total aggregate offering: $9.1M
- Issuer portion: $7.0M
- Selling securityholders: $2.1M
- Price per security: $2.0000
- Securities offered: Equity (common or preferred stock)
- Broker-dealer CRD: 136352
- Audit status: Audited
- Auditor: Ankit Consulting Inc. (for 2019 audited financials)
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001743261
- Organized in: NV
- Incorporated: 2017
- Address: 16776 BERNARDO CENTER DRIVE, SAN DIEGO, CA, 92128
- Phone: 619-818-2411
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $321K
- Cash & equivalents: $71K
- Total liabilities: $383K
- Stockholder equity: $-62K
- Net income: $-140K
People (1)
| Name | Role | Location |
|---|
| Ronald N. Vance | Signer | SAN DIEGO, CA |
Other Reg A filings by this issuer (9)
More